The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
暂无分享,去创建一个
A Daugherty | D. Rader | E. Puré | A. Daugherty | J. Leferovich | Sam Chen | D J Rader | E Puré | D Delfel-Butteiger | S Chen | J Leferovich | S E Roselaar | S. Roselaar | D. Delfel-Butteiger | S. Chen | Dustie Delfel-Butteiger
[1] J. D. Smith,et al. Mouse models of atherosclerosis. , 1998, Laboratory animal science.
[2] J. D. Smith,et al. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[3] C. Bell,et al. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. , 1996, The American journal of pathology.
[4] A. Daugherty,et al. Lymphocyte populations in atherosclerotic lesions of apoE -/- and LDL receptor -/- mice. Decreasing density with disease progression. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[5] M. Cybulsky,et al. Immunology of atherosclerosis: the promise of mouse models. , 1996, The American journal of pathology.
[6] G. Hansson,et al. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice. , 1996, The American journal of pathology.
[7] D. L. Fletcher,et al. Immunologic basis of transplant-associated arteriosclerosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[8] E M Rubin,et al. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. , 1995, Journal of lipid research.
[9] S. Young,et al. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[10] G. Schonfeld,et al. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. , 1995, The Journal of clinical investigation.
[11] P. Tipping,et al. Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit. , 1995, Atherosclerosis.
[12] J. Campbell,et al. T lymphocytes affect smooth muscle cell phenotype and proliferation. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[13] P. M. Davis,et al. Immune complexes of LDL induce atherogenic responses in human monocytic cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[14] A. Daugherty,et al. Lipoprotein oxidation as a mediator of atherogenesis: insights from pharmacological studies. , 1995, Cardiovascular research.
[15] E. Miller,et al. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[16] J. Qiao,et al. Immune-deficient mice develop typical atherosclerotic fatty streaks when fed an atherogenic diet. , 1994, The Journal of clinical investigation.
[17] S. Gordon,et al. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. , 1994, Immunology letters.
[18] T. Drake,et al. Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[19] P. Libby,et al. Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[20] L. Fong,et al. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma. , 1994, Journal of lipid research.
[21] A. Becker,et al. Specialized membrane contacts between immunocompetent cells in human atherosclerotic plaques. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[22] V. Ord,et al. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[23] R. Ross,et al. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[24] N. Maeda,et al. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[25] D. Steinberg,et al. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[26] E. Emeson,et al. Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. , 1993, The American journal of pathology.
[27] N. Mackman,et al. Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms. , 1993, The Journal of clinical investigation.
[28] P. Quesenberry,et al. Regulation of macrophage alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. , 1993, The Journal of clinical investigation.
[29] Qingbo Xu,et al. Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.
[30] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[31] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[32] N. Maeda,et al. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[33] J. Salonen,et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.
[34] G. Hansson,et al. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. , 1992, The Journal of clinical investigation.
[35] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[36] G. Hansson,et al. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[37] S. Holm,et al. T lymphocytes inhibit the vascular response to injury. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[38] G. Hansson,et al. Interferon‐γ Inhibits Arterial Stenosis After Injury , 1991 .
[39] A Daugherty,et al. The effects of probucol on the progression of atherosclerosis in mature Watanabe heritable hyperlipidaemic rabbits , 1991, British journal of pharmacology.
[40] P. Libby,et al. Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[41] T. Shimokama,et al. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[42] L. Fong,et al. Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma. , 1990, The Journal of biological chemistry.
[43] A Daugherty,et al. Probucol attenuates the development of aortic atherosclerosis in cholesterol‐fed rabbits , 1989, British journal of pharmacology.
[44] G. Hansson,et al. Detection of activated T lymphocytes in the human atherosclerotic plaque. , 1989, The American journal of pathology.
[45] O. Kocher,et al. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. , 1988, Atherosclerosis.
[46] A. Zlotnik,et al. Induction of class I and class II MHC antigen expression on murine bone marrow-derived macrophages by IL-4 (B cell stimulatory factor 1). , 1988, Journal of immunology.
[47] E. Emeson,et al. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. , 1988, The American journal of pathology.
[48] R. Williams,et al. Quantitative assessment of atherosclerotic lesions in mice. , 1987, Atherosclerosis.
[49] J. Bluestone,et al. Identification of a monoclonal antibody specific for a murine T3 polypeptide. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[50] G. Bondjers,et al. Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.
[51] P. Steeg,et al. Regulation of murine macrophage Ia antigen expression by a lymphokine with immune interferon activity , 1982, The Journal of experimental medicine.
[52] P. Edwards,et al. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[53] W. Paul,et al. A mouse IgM allotypic determinant (Igh-6.5) recognized by a monoclonal rat antibody. , 1981, Journal of immunology.
[54] C. Glueck,et al. Quantitative analysis of cholesterol in 5 to 20 μl of plasma , 1974 .